Piramal Healthcare's Q3 performance
Ajay Piramal, chairman of Piramal Healthcare, said, "Q3 EBITDA margins are at 19.9 per cent vs 15 per cent (YoY). The EBITDA margin improved on reduction in raw material cost. Also, Q3 domestic market growth at 21.5 per cent (YoY)."
